NICE recommends new psoriasis treatment
The National Institute for Health and Care Excellence has recommending a new treatment for psoriasis. Secukinumab (Cosentyx; Novartis) is recommended as an option for treating some adults with plaque psoriasis if they are unable to take standard systemic therapies and if the drug is provided with the agreed patient access scheme discount.
Citation: Electronicjuice DOI: 10.1211/PJ.2015.20068636
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.